Randomized Phase-III Study on HIPEC in Ovarian Cancer Impact on Patient Management

被引：0
|
作者：
Meier, W. [1 ]
机构：
[1] Univ Frauenklin Dusseldorf, Moorenstr 5, D-40225 Dusseldorf, Germany
来源：
ONKOLOGE | 2018年 / 24卷 / 09期
关键词：
PRIMARY SURGERY; CHEMOTHERAPY;
D O I：
10.1007/s00761-018-0424-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：737 / 738
页数：2
相关论文
共 50 条
  • [1] Comment on: Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
    Batista, Thales Paulo
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S630 - S630
  • [2] Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
    Spiliotis, J.
    Halkia, E.
    Lianos, E.
    Kalantzi, N.
    Grivas, A.
    Efstathiou, E.
    Giassas, S.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (05) : 1570 - 1575
  • [3] Comment on: Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
    Thales Paulo Batista
    Annals of Surgical Oncology, 2017, 24 : 630 - 630
  • [4] Cytoreductive Surgery and HIPEC in Recurrent Epithelial Ovarian Cancer: A Prospective Randomized Phase III Study
    J. Spiliotis
    E. Halkia
    E. Lianos
    N. Kalantzi
    A. Grivas
    E. Efstathiou
    S. Giassas
    Annals of Surgical Oncology, 2015, 22 : 1570 - 1575
  • [5] Randomisierte Phase-III-Studie zu HIPEC beim OvarialkarzinomAuswirkungen auf das VorgehenRandomized phase III study on HIPEC in ovarian cancerImpact on patient management
    W. Meier
    Der Onkologe, 2018, 24 (9): : 737 - 738
  • [6] Randomized phase-III study in nonseminomatous testicular tumor
    Rexer, H
    UROLOGE A, 2004, 43 (11): : 1432 - 1433
  • [7] CARBOPLATIN AND IFOSFAMIDE IN OVARIAN-CANCER PHASE-II AND PHASE-III TRIALS
    WILTSHAW, E
    PERREN, TJ
    FRYATT, ID
    BLAKE, PR
    HARPER, P
    SLEVIN, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 : S48 - S50
  • [8] ADVERSE EVENTS AFTER HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) FOR STAGE III OVARIAN CANCER: PHASE III OVHIPEC STUDY
    Koole, S.
    van Driel, W.
    Sikorska, K.
    van Leeuwen, J. Schagen
    Schreuder, H.
    Hermans, R.
    de Hingh, I.
    van der Velden, J.
    Arts, H.
    Massuger, L.
    Aalbers, A.
    Verwaal, V.
    van de Vijver, K.
    Aaronson, N.
    Sonke, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 38 - 39
  • [9] ADVERSE EVENTS AFTER HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) FOR STAGE III OVARIAN CANCER: PHASE III OVHIPEC STUDY
    Koole, S.
    van Driel, W.
    Sikorska, K.
    van Leeuwen, J. Schagen
    Schreuder, H.
    Hermans, R.
    de Hingh, I.
    van der Velden, J.
    Arts, H.
    Massuger, L.
    Aalbers, A.
    Verwaal, V.
    van de Vijver, K.
    Aaronson, N.
    Sonke, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1549 - 1550
  • [10] PHASE-III RANDOMIZED STUDY OF ZOLADEX VERSUS STILBESTROL IN THE TREATMENT OF ADVANCED PROSTATE-CANCER
    WAYMONT, B
    LYNCH, TH
    DUNN, JA
    EMTAGE, LA
    ARKELL, DG
    WALLACE, DMA
    BLACKLEDGE, GRP
    BRITISH JOURNAL OF UROLOGY, 1992, 69 (06): : 614 - 620
12345